D. Langbehn

发表

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

Nick C Fox, H. D. Rosas, R. Reilmann, 2009, The Lancet Neurology.

fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease.

Jane S. Paulsen, Stephen M. Rao, M. Benjamin, 2004, AJNR. American journal of neuroradiology.

Neurocognitive signs in prodromal Huntington disease.

Jane S. Paulsen, E. Aylward, N. Carlozzi, 2011, Neuropsychology.

Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis

R. Reilmann, J. Long, J. Mills, 2017, JAMA neurology.

Verbal episodic memory declines prior to diagnosis in Huntington's disease

Jane S. Paulsen, J. Brandt, M. Hayden, 2007, Neuropsychologia.

Huntington disease: natural history, biomarkers and prospects for therapeutics

Jane S. Paulsen, R. Reilmann, J. Long, 2014, Nature Reviews Neurology.

Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment.

Jane S. Paulsen, P. Nopoulos, R. Barker, 2011, Brain : a journal of neurology.

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

Jane S. Paulsen, D. Falush, M. Hayden, 2004, Clinical genetics.

White Matter Volume and Cognitive Dysfunction in Early Huntington's Disease

Jane S. Paulsen, P. Nopoulos, A. Mikos, 2005, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Preparing for preventive clinical trials: the Predict-HD study.

Jane S. Paulsen, M. Hayden, E. Aylward, 2006, Archives of neurology.

Detection of Huntington’s disease decades before diagnosis: the Predict-HD study

Jane S. Paulsen, M. Hayden, E. Aylward, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Scientific rigor and the art of motorcycle maintenance

E. Wagenmakers, P. Holmans, M. Munafo, 2014, Nature Biotechnology.

Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study

Jane S. Paulsen, E. Aylward, C. Ross, 2009, Movement disorders : official journal of the Movement Disorder Society.

Abnormal brain structure in children with isolated clefts of the lip or palate.

P. Nopoulos, V. Magnotta, D. Langbehn, 2007, Archives of pediatrics & adolescent medicine.

Self-paced timing detects and tracks change in prodromal Huntington disease.

Jane S. Paulsen, Julie C Stout, Jane S Paulsen, 2010, Neuropsychology.

Distinguishing between Hypochondriasis and Somatization Disorder: A Review of the Existing Literature

D. Langbehn, R. Noyes, S. Stuart, 2006, Psychotherapy and Psychosomatics.

Specific phobia of illness: search for a new subtype.

D. Langbehn, R. Noyes, C. Carney, 2004, Journal of anxiety disorders.

Stimulating neural plasticity with real‐time fMRI neurofeedback in Huntington's disease: A proof of concept study

G. Rees, R. Reilmann, N. Weiskopf, 2017, Human brain mapping.

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy

Stéphane Lehéricy, Christopher Kennard, Alexandra Durr, 2011, Human brain mapping.

CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches

Jane S. Paulsen, Jane S Paulsen, M. Hayden, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Tapping linked to function and structure in premanifest and symptomatic Huntington disease

S J Tabrizi, R I Scahill, H. D. Rosas, 2010, Neurology.

Longitudinal change in regional brain volumes in prodromal Huntington disease

Vincent A Magnotta, Jane S. Paulsen, Jane S Paulsen, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

Chris Frost, Alexandra Durr, Ralf Reilmann, 2013, The Lancet Neurology.

Behavioral inhibition and reward processing in college binge drinkers with and without marijuana use.

J. Vaidya, D. O’Leary, D. Langbehn, 2020, Drug and alcohol dependence.

A Pilot Follow-Up Study of Older Alcohol Dependent COGA Adults.

L. Bierut, J. Nurnberger, M. Hesselbrock, 2019, Alcoholism, clinical and experimental research.

Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease

G. Rees, A. Razi, C. Clark, 2017, Human brain mapping.

Social function in boys with cleft lip and palate: Relationship to ventral frontal cortex morphology

P. Nopoulos, D. Langbehn, A. Boes, 2007, Behavioural Brain Research.

Activity or connectivity? A randomized controlled feasibility study evaluating neurofeedback training in Huntington’s disease

Sophia E. Pépés, G. Rees, R. Reilmann, 2020, Brain communications.

Activity-is better than connectivity-neurofeedback training in Huntington’s disease

Sophia E. Pépés, G. Rees, R. Reilmann, 2018, bioRxiv.

Increased risk of side-effects in psychiatric patients treated with clozapine and carbamazepine: a reanalysis.

D. Langbehn, B. Alexander, 2000, Pharmacopsychiatry.

Structural and Functional Brain Network Correlates of Depressive Symptoms in Premanifest Huntingtons Disease

A. Razi, C. Clark, P. McColgan, 2017 .

Association Between Age and Familial Risk for Alcoholism on Functional Connectivity in Adolescence.

J. Vaidya, D. Langbehn, S. Kuperman, 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

Design optimization for clinical trials in early‐stage manifest Huntington's disease

R. Reilmann, E. Aylward, C. Frost, 2017, Movement disorders : official journal of the Movement Disorder Society.

Cortical Thickness in Adolescents with a Family History of Alcohol Use Disorder

J. Vaidya, D. Langbehn, S. Kuperman, 2018, Alcoholism: Clinical and Experimental Research.

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

Chris Frost, Alexandra Durr, Ralf Reilmann, 2012, The Lancet Neurology.

Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance

R. Reilmann, R. Keogh, C. Frost, 2016, PLoS currents.

Criteria for success in safety and tolerability trials

D. Langbehn, 2015, The Lancet Neurology.

Association of CAG Repeats With Long-term Progression in Huntington Disease.

R. Reilmann, J. Long, J. Mills, 2019, JAMA neurology.

Abnormal brain development in child and adolescent carriers of mutant huntingtin

P. Nopoulos, V. Magnotta, D. Langbehn, 2019, Neurology.

Cerebral cortex structure in prodromal Huntington disease

Hans J. Johnson, Vincent A. Magnotta, Douglas R. Langbehn, 2010, Neurobiology of Disease.

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children

P. Nopoulos, D. Langbehn, E. Wild, 2022, Movement disorders : official journal of the Movement Disorder Society.

Neurofilament light protein as a blood biomarker for Huntington's disease in children

P. Nopoulos, D. Langbehn, E. Wild, 2021, medRxiv.

"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.

Jane S. Paulsen, E. Aylward, C. Ross, 2010, The Journal of neuropsychiatry and clinical neurosciences.

Q-motor – Quantitative motor assessments: Potential novel endpoints for clinical trials in pre-manifest and symptomatic Huntington's disease – 36 months longitudinal results from the multicenter TRACK-HD study

R. Reilmann, D. Langbehn, B. Leavitt, 2013 .

Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial

S. Hersch, E. M. Fine, D. Langbehn, 2022, Movement disorders : official journal of the Movement Disorder Society.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Enrico Amico, Philippe Allain, Mark Mühlau, 2017, The Lancet. Neurology.

Response to Lee et al.

D. Langbehn, 2022, American journal of human genetics.

Contents Vol. 8, 2011

Jane S. Paulsen, Robert P. Davis, J. L. Mesa, 2011, Neurodegenerative Diseases.

The Iowa Personality Disorder Screen: development and preliminary validation of a brief screening interview.

P. Links, R. Cadoret, L. Clark, 1999, Journal of personality disorders.

DORSAL COLUMN Grey Matter Operationalizing compensation over time in neurodegenerative disease

J. Long, J. Mills, A. Razi, 2022 .

Developmental Trajectory of Height, Weight, and BMI in Children and Adolescents at Risk for Huntington’s Disease: Effect of mHTT on Growth

P. Nopoulos, D. Langbehn, K. Mathews, 2020, Journal of Huntington's disease.

A sibling adoption study of adult attachment: The influence of shared environment on attachment states of mind

D. Langbehn, Stephan Arndt, K. Caspers, 2007, Attachment & human development.

Behavioral features in child and adolescent huntingtin gene‐mutation carriers

P. Nopoulos, V. Magnotta, D. Langbehn, 2022, Brain and behavior.

Intellectual enrichment and genetic modifiers of cognitive function in Huntington's disease

Langbehn, P. Holmans, D. Langbehn, 2022, medRxiv.

Relationship between service effectiveness and satisfaction among persons receiving Medicaid mental health services.

D. Langbehn, J. Rohrer, B. Rohland, 2000, Psychiatric services.

HYPOCHONDRIASIS AND FEAR OF DEATH

D. Langbehn, R. Noyes, S. Longley, 2002, The Journal of nervous and mental disease.

Longitudinal Change in Striatal Volume in Pre-Clinical Huntington's Disease

D. Langbehn, P. Nopoulos, C. Ross, 2009, NeuroImage.

The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease

Julie C. Stout, Douglas R. Langbehn, Alexandra Durr, 2015, Neuropsychologia.

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

K. Blennow, R. Roos, S. Tabrizi, 2017, The Lancet Neurology.

Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating Scales

D. Langbehn, John H. Warner, Yaning Wang, 2020, Journal of clinical pharmacology.

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD

Merit Cudkowicz, Shiyang Ma, E Ray Dorsey, 2017, Neurology.

Validation of a prognostic index for Huntington's disease

Jane S. Paulsen, J. Long, S. Tabrizi, 2017, Movement disorders : official journal of the Movement Disorder Society.

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.

S. Tabrizi, D. Langbehn, B. Leavitt, 2015, The Journal of clinical investigation.

Polyunsaturated fatty acid composition and childhood adversity: Independent correlates of depressive symptom persistence

W. Coryell, D. Langbehn, L. Dindo, 2017, Psychiatry Research.

A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease

David J. Arenillas, O. Hermanson, M. Hayden, 2015, Nature Neuroscience.

Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease

Lisa M Anderson, L. Raymond, M. Hayden, 2018, Science Translational Medicine.

Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington’s disease

P. Holmans, S. Tabrizi, D. Langbehn, 2022, Brain communications.

Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients.

D. Langbehn, K. Duff, L. Beglinger, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ncidence of Delirium and Associated Mortality in ematopoietic Stem Cell Transplantation Patients

D. Langbehn, K. Duff, L. Beglinger, 2006 .

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease

C. Frost, R. Roos, S. Tabrizi, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Clinical correlates of self-mutilation among psychiatric inpatients.

D. Langbehn, B. Pfohl, 1993, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Distinct contributions of conduct and oppositional defiant symptoms to adult antisocial behavior: evidence from an adoption study.

R. Cadoret, D. Langbehn, W. Yates, 1998, Archives of general psychiatry.

Suicidal Behavior in Prodromal Huntington Disease

Jane S. Paulsen, J. Mills, D. Langbehn, 2011, Neurodegenerative Diseases.

Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis

T. Robbins, B. Sahakian, G. Rees, 2020, The Lancet Neurology.

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

Chris Frost, Nick C Fox, Christopher Kennard, 2011, The Lancet Neurology.

A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes

P. Holmans, R. Roos, S. Tabrizi, 2019, EBioMedicine.

Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease

P. Holmans, S. Tabrizi, D. Langbehn, 2017, Scientific Reports.

The association of the D2S2944 124 bp allele with recurrent early onset major depressive disorder in women

R. Cadoret, D. Langbehn, R. Philibert, 2003, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

Psychiatric Symptoms in Huntington’s Disease before Diagnosis: The Predict-HD Study

Jane S. Paulsen, Douglas R. Langbehn, D. Langbehn, 2007, Biological Psychiatry.

Early atrophy of pallidum and accumbens nucleus in Huntington’s disease

Jeroen van der Grond, Douglas R. Langbehn, Rachael I. Scahill, 2010, Journal of Neurology.

Obsessive and compulsive symptoms in prediagnosed Huntington's disease.

Jane S. Paulsen, E. Aylward, H. Paulson, 2008, The Journal of clinical psychiatry.

Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease.

Jane S. Paulsen, M. Hayden, E. Aylward, 2007, Brain : a journal of neurology.

Diffusion Tensor Imaging in Preclinical Huntington’s Disease

Jane S. Paulsen, Vincent A. Magnotta, Jinsuh Kim, 2009, Brain Imaging and Behavior.

Estimating Premorbid IQ in the Prodromal Phase of a Neurodegenerative Disease

Jane S. Paulsen, J. Mills, E. Aylward, 2011, The Clinical neuropsychologist.

Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease

G. Rees, R. Roos, S. Tabrizi, 2021, Movement disorders : official journal of the Movement Disorder Society.

Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials

S. Hersch, D. Langbehn, 2020, Movement disorders : official journal of the Movement Disorder Society.

Depression spectrum disease, I: The role of gene-environment interaction.

R. Cadoret, D. Langbehn, G. Winokur, 1996, The American journal of psychiatry.

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Nick C Fox, T. Heskes, C. Kennard, 2019, Brain : a journal of neurology.

Acid-Sensing Ion Channel-1a in the Amygdala, a Novel Therapeutic Target in Depression-Related Behavior

Douglas R. Langbehn, John A. Wemmie, Jason E. Allen, 2009, The Journal of Neuroscience.

Longer CAG repeat length is associated with shorter survival after disease onset in Huntington disease.

D. Langbehn, 2021, American journal of human genetics.

Mild cognitive impairment in prediagnosed Huntington disease

J. Mills, D. Harrington, D. Langbehn, 2010, Neurology.

Hypochondriacal Symptoms Associated With a Less Therapeutic Physician-Patient Relationship

D. Langbehn, R. Noyes, S. Longley, 2010, Psychiatry.

Contributions of attachment style and perceived social support to lifetime use of illicit substances.

R. Cadoret, D. Langbehn, K. Caspers, 2005, Addictive behaviors.

Impact of Binge Drinking During College on Resting State Functional Connectivity

J. Vaidya, D. Langbehn, S. Kuperman, 2021, bioRxiv.

The Trail Making Test in prodromal Huntington disease: Contributions of disease progression to test performance

Jane S. Paulsen, J. Mills, D. Harrington, 2011, Journal of clinical and experimental neuropsychology.

Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images

Michael I. Miller, Qi Peng, Qing Li, 2010, NeuroImage.

Probability of Obsessive and Compulsive Symptoms in Huntington’s Disease

Jane S. Paulsen, D. Langbehn, K. Duff, 2007, Biological Psychiatry.

A17 HD brain-train: neuroplasticity as a target to improve function in huntington’s disease

Nikolaus Weiskopf, Douglas R. Langbehn, Sarah J. Tabrizi, 2016 .

Results of the citalopram to enhance cognition in Huntington disease trial

Jane S. Paulsen, D. Langbehn, J. Caviness, 2014, Movement disorders : official journal of the Movement Disorder Society.

Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease

Jane S. Paulsen, H. Paulson, D. Langbehn, 2009, Journal of clinical psychopharmacology.

Test of an Interpersonal Model of Hypochondriasis

B. A. Muller, D. Langbehn, R. Noyes, 2003, Psychosomatic medicine.

The Iowa Personality Disorder Screen (IPDS): Preliminary results of the validation of a self-administered version in a Dutch population

D. Langbehn, G. L. Heck, P. Hodiamont, 2010 .

Genetic and environmental risk factors for the onset of drug use and problems in adoptees.

R. Cadoret, D. Langbehn, E. Troughton, 2003, Drug and alcohol dependence.

Prevalence and correlates of illness worry in the general population.

D. Langbehn, R. Noyes, S. Hillis, 2005, Psychosomatics.

Childhood antecedents of hypochondriasis.

D. Langbehn, R. Noyes, S. Longley, 2002, Psychosomatics.

The Iowa Personality Disorder Screen: A validation study in a psychiatric population that receives long-term group psychotherapy for personality related problems.

D. Langbehn, U. Romild, G. Pedersen, 2018, Personality and mental health.

Personality dysfunction among somatizing patients.

B. A. Muller, D. Langbehn, R. Noyes, 2001, Psychosomatics.

Standardizing the CAP Score in Huntington's Disease by Predicting Age-at-Onset.

J. Long, J. Mills, D. Langbehn, 2022, Journal of Huntington's disease.

Biology-Environment Interaction and Evocative Biology-Environment Correlation: Contributions of Harsh Discipline and Parental Psychopathology to Problem Adolescent Behaviors

R. Cadoret, J. Knutson, D. Langbehn, 2003, Behavior genetics.

Earliest functional declines in Huntington disease

D. Langbehn, K. Duff, L. Beglinger, 2010, Psychiatry Research.

Discriminant analysis using the unweighted sum of binary variables: a comparison of model selection methods.

R F Woolson, D. Langbehn, R. Woolson, 1997, Statistics in medicine.

Operationalizing compensation over time in neurodegenerative disease

G. Rees, J. Long, J. Mills, 2017, Brain : a journal of neurology.

Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population.

R. Cadoret, D. Langbehn, R. Philibert, 2003, Comprehensive psychiatry.

Progressive alterations in white matter microstructure across the timecourse of Huntington's disease

S. Tabrizi, D. Langbehn, B. Leavitt, 2023, Brain and behavior.

Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease.

Jane S. Paulsen, D. Langbehn, J. Caviness, 2015, Journal of Huntington's disease.

Does interval between screening and baseline matter in HD cognitive clinical trials?

Jane S. Paulsen, D. Langbehn, J. Caviness, 2014, Journal of Huntington's disease.

Personality traits and negative consequences associated with binge drinking and marijuana use in college students

J. Vaidya, D. Langbehn, S. Kuperman, 2019, The American journal of drug and alcohol abuse.

Reliability and validity of an internalizing symptom scale based on the adolescent and adult Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA)

M. Hesselbrock, K. Bucholz, M. Schuckit, 2018, The American journal of drug and alcohol abuse.

Challenges assessing clinical endpoints in early Huntington disease

Jane S. Paulsen, R. Barker, D. Langbehn, 2010, Movement disorders : official journal of the Movement Disorder Society.

Co-morbid health conditions at mid-life in the Iowa adoptees.

R. Cadoret, D. Langbehn, Stephan Arndt, 2007, Addictive behaviors.

Corpus callosal atrophy in premanifest and early Huntington's disease.

R. Reilmann, C. Frost, R. Roos, 2013, Journal of Huntington's disease.

The direct medical costs of Huntington’s disease by stage. A retrospective commercial and Medicaid claims data analysis

Won Chan Lee, D. Langbehn, K. Anderson, 2013, Journal of medical economics.

Predictors of diagnosis in Huntington disease

Jane S. Paulsen, D. Langbehn, 2007, Neurology.

The adult antisocial syndrome with and without antecedent conduct disorder: comparisons from an adoption study.

R. Cadoret, D. Langbehn, Douglas R. Langbehn, 2001, Comprehensive psychiatry.

Association of a D2S2944 allele with depression specifically among those with substance abuse or antisocial personality.

R. Cadoret, D. Langbehn, R. Philibert, 2006, Drug and alcohol dependence.

Normative data on and psychometric properties of Verbal and Visual Indexes of the RBANS in older adults

James G. Scott, Mike R. Schoenberg, D. Langbehn, 2009, The Clinical neuropsychologist.

The potential of composite cognitive scores for tracking progression in Huntington's disease.

C. Frost, R. Roos, S. Tabrizi, 2014, Journal of Huntington's disease.

Natural biological variation of white matter microstructure is accentuated in Huntington's disease

G. Rees, R. Roos, S. Tabrizi, 2018, Human brain mapping.

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

R. Reilmann, K. Marder, J. Corey-Bloom, 2019, The Lancet Neurology.

Hypertension Is Associated With an Earlier Age of Onset of Huntington's Disease

P. Nopoulos, D. Langbehn, L. Harshman, 2020, Movement disorders : official journal of the Movement Disorder Society.

Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index.

Jane S. Paulsen, D. Langbehn, H. Westervelt, 2007, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Effects of continuity of care and patient dispositional factors on the physician-patient relationship.

D. Langbehn, R. Noyes, S. Longley, 2011, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Test–Retest Reliability of Measures Commonly Used to Measure Striatal Dysfunction across Multiple Testing Sessions: A Longitudinal Study

S. Tabrizi, D. Langbehn, M. Papoutsi, 2018, Front. Psychol..

Paths of Genetic and Environmental Influence:The Routes Connecting Personality Disorders with Substance Use Disorders

R. Cadoret, D. Langbehn, E. Troughton, 2005 .

Neuropsychiatry and White Matter Microstructure in Huntington’s Disease

G. Rees, J. Long, R. Roos, 2015, Journal of Huntington's disease.

Patterns of serotonergic antidepressant usage in prodromal Huntington disease

Jane S. Paulsen, D. Langbehn, K. Rowe, 2012, Psychiatry Research.

Examining the repeatable battery for the assessment of neuropsychological status: factor analytic studies in an elderly sample.

James G. Scott, Mike R. Schoenberg, D. Langbehn, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The impact of seizure quality on ect treatment efficacy

D. Langbehn, T. Nickl-Jockschat, M. Grözinger, 2020, Psychiatry Research.

Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease

R. Roos, S. Tabrizi, D. Langbehn, 2020, Psychological Medicine.

Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's Disease

P. Nopoulos, V. Magnotta, D. Langbehn, 2022, Movement disorders : official journal of the Movement Disorder Society.

Natural variation in sensory‐motor white matter organization influences manifestations of Huntington's disease

J. Rothwell, G. Rees, R. Reilmann, 2016, Human brain mapping.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.

Self-reported life satisfaction.

D. Langbehn, B. Rohland, 1997, The American journal of psychiatry.